Advisory Board and Editors Nephrology
Cristina Capusa
Associate Professor of Nephrology, PhD and Habilitated Doctor in Nephrology at the "Carol Davila" University of Medicine and Pharmacy in Bucharest and attending physician (consultant in Nephrology and Internal Medicine) at a university-affiliated tertiary-care hospital. Former secretary of the Romanian Society of Nephrology and currently member of the society board.
Research interest in: chronic kidney disease, renal anemia, intravenous iron therapy, mineral metabolism disorders in chronic kidney disease, oxidative stress in kidney disease and glomerular diseases.
Bang-Gee Hsu
Dr. Bang-Gee Hsu obtained his MD from the Chinese Medical University, Taichung, Taiwan (1989 - 1996) and his PhD from the Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan (2003-2006).
Dr. Hsu is currently Professor at the School of Medicine, Tzu Chi University, Hualien, Taiwan (2015-present), Director of the Department of Internal Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan (2018-present), and Director of the Division of Nephrology Department of Internal Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan (2014-present).
His research interests include Nephrology, Critical Care Medicine and Internal Medicine.
Florian Lang
Professor of Physiology and Head of the Department for Physiology I in Tübingen, Member of the German Academy of Natural Sciences Leopoldina. Former President of the Geman Physiological Society and the Germany Society of Nephrology.
Brittany N Lasseigne
Brittany N. Lasseigne, PhD is an Assistant Professor of Cell, Developmental and Integrative Biology at The University of Alabama at Birmingham School of Medicine. She trained in Biotechnology, Science, and Engineering at Mississippi State University (B.S.) and the University of Alabama in Huntsville (Ph.D.) and completed a postdoctoral fellowship in genetics and genomics at the HudsonAlpha Institute for Biotechnology.
Her lab develops and applies genomic- and data-driven strategies (including single-cell and long-read sequencing) to discover biological signatures that might be used to improve patient care and provide insight into the cellular and molecular processes contributing to disease, especially for diseases impacting the brain and/or kidney. Their recent work includes prioritizing drug repurposing candidates for cancers and polycystic kidney disease, evaluating preclinical models and cross-species transcriptomic signatures to improve disease modeling, and applying single-cell and long-read technologies to neurological disease tissues to understand the role that context plays in disease etiology, progression, and treatment.
The Lasseigne Lab is currently focused on integrating genomics data, functional annotations, and patient information with machine learning and regulatory network approaches across diseases that impact the brain or kidney to discover novel mechanisms in disease etiology and progression, identify genome-driven therapeutic targets and opportunities for drug repositioning and repurposing, determine clinically-relevant biomarkers, and understand how cellular context contributes to these diseases. Collectively, these distinct projects all apply genetics and genomics to human diseases and build tools to accelerate future research. Their lab also develops data science software and analytical pipelines that are open-source, well-documented, and hosted by third-party code distributors, critical for facilitating reproducibility and enabling the research community to use the methods they develop.
Yoshinori Marunaka
Prof. Marunaka is the President and the Representative Director, Director of Clinical, and Director of Medical Research Institute, Kyoto Industrial Health Association; Professor, Research Organization of Science and Technology, Ritsumeikan University; Professor Emeritus, Kyoto Prefectural University of Medicine; Former President, Physiological Society of Japan. Former President, International Society of Cancer Metabolism. MD (1979), PhD (1985), Kyoto Prefectural University of Medicine; National License of Physician and Surgeon, Japan (1979). He was Professor and Chairperson, Departments of Molecular Cell Physiology and Bio-Ionomics, Kyoto Prefectural University of Medicine, Japan, and Director and Professor, Japan Institute for Food Education and Health, St. Agnes’ University. He was awarded “Vebleo Nanomedicine Scientist Award” (Sweden), “Marco Polo della Scienza Italiana” (Italy), The Premier's Research Excellence Award (Canada), Scholar Award (Medical Research Council of Canada) and Research Award from National Kidney Foundation of USA. He has obtained more than 60 research grants, published more than 270 peer reviewed articles, and provided more than 30 invited plenary lectures at international congresses and research conferences. h-index 47, i10-index 190, Citation 7498
Stefano Menini
Associate professor of Human Nutrition, School of Medicine and Psychology, Department of Clinical and Molecular Medicine, "La Sapienza" University, Rome, Italy. PhD in Biology and Pathology of Ageing and member of the European Association for the Study of Diabetes (EASD). Research areas: Diabetes, Endocrinology and Metabolism.
Laurent Metzinger
Laurent Metzinger has completed his PhD in Biological Sciences and Pharmaceutical studies in Strasbourg, France and was a postdoctoral fellow from the University of Oxford (UK) in a leading lab on Duchenne muscular Dystrophy (Pr. Kay Davies). He works on microRNA regulation in the HEMATIM team in Amiens, and focuses on anemia and related vascular disorders associated with Chronic Kidney DIsease. He has authored some of the first papers showing a role for microRNAs in CKD and published in reputed journals, including Nature and Cell. He teaches Biochemistry, Genetics and Molecular Biology in the Pharmacy School of Amiens (Université de Picardie Jules Verne).
Shobana Navaneethabalakrishnan
I received my PhD in Reproductive Endocrinology from University of Madras, India where I studied the molecular mechanism underlying the repression of follicle stimulating hormone receptor and androgen receptor in Sertoli cells of F1 progeny rats with gestational exposure to hexavalent chromium. I have successfully attained inter-laboratory collaboration to study the effect of gestational exposure to excess hexavalent chromium on insulin signaling molecules and glucose homeostasis in F1 progeny rats. Currently, my research focus is to understand the role of gonadal macrophage polarization in reproductive dysfunction associated with hypertension in both men and women.
Gianpaolo Reboldi
Professor of Nephrology and Consultant Physician at the University of Perugia
Academic Degrees:
Doctoral Degree in Medicine and Surgery (MD) from the Faculty of Medicine and Surgery, University of Perugia, Italy
Master of Science (MSc) from The Faculty of Medicine, University of Newcastle upon Tyne, Newcastle Upon Tyne, United Kingdom
Dottore di Ricerca (PhD) in Applied Pathophysiology from The University of Florence, Florence, Italy
Scientific Interests:
Renal and Cardiovascular Diseases, Diabetes, Hypertension, Clinical Epidemiology
Chih-Chung Shiao
Dr. Chih-Chung Shiao is an associate professor and a nephrologist.
He currently is the deputy superintendent of medical research and education department, chairman of the academic research committee, and attending physician of the Nephrology Division in Camillian Saint Mary’s Hospital Luodong, Taiwan.
Dr. Chih-Chung Shiao has published a total of more than 70 papers in SCI journals. His research interests cover acute kidney injury, autonomic cardiac function, critical care nephrology, heart failure, survival, chronic kidney disease, and uremia.
Edward R Smith
Professor Edward Smith is an Associate Professor in the Department of Medicine, University of Melbourne and Senior Scientist at the Kincaid-Smith Renal Laboratories, Department of Nephrology, The Royal Melbourne Hospital. He is interested in mineral metabolism and kidney disease.
Ashish K Solanki
My Ph.D. (Structural Biology/Biochemistry) focused on studying the pathogenesis of the HIV-1 virus and finding ways to combat its infection. It included structural analysis of the interaction of HIV-1 gp120 with neutralizing and non-neutralizing mAbs, chimeric antibody-CD4 IgG2, and with the host cell surface glycoprotein CD4. Although in the past I have been working on structural, biophysical, and biochemical methods to answer some of the critical questions in biology, my interest in cell signaling and protein trafficking enabled me to join the Dept. of Nephrology, MUSC, South Carolina as a postdoctoral fellow. I have gained a large amount of experience in the field of protein biochemistry and substantial knowledge of podocyte biology during months spent as a postdoc. I explored the role of the exocyst complex in podocyte development and functions, critical aspects of cell signaling, studying pathophysiology and diseases progression caused by mutations in slit diaphragm proteins, which not only helped to get publications but increased my understanding in the field of podocyte biology. The understanding and development of animal model systems in the lab further helped me to strengthen my podocyte experience. I also worked on developing a novel cell-based assay to diagnose recurrent Focal and Segmental Glomerulosclerosis.